Royalty Pharma plc has completed a transaction to monetize remaining fixed payments on the MorphoSys Development Funding Bonds for $511 million in cash, resulting in total proceeds of $530 million ...

Through that transaction, Royalty Pharma acquired royalties on Tremfya and other development stage assets including trontinemab. In connection with that transaction, Royalty Pharma purchased $300 ...

Royalty Pharma plc (Nasdaq: RPRX) today announced the closing of a transaction to monetize the remaining fixed payments on the MorphoSys Development Funding Bonds for $511 million in upfront cash.

Today, world leaders will gather at Auschwitz to mark the 80th anniversary of its liberation, including royalty from around the world. Among the royals attending the solemn affair are the UK's ...

Business development is a critical function of any organization—small or larger enterprises. And over the years, one thing I've noticed is that businesses that are sustainable continually and ...

Yet when it comes to Africa’s development, we too often mistake discussion for progress. The continent hosts some of the world’s fastest-growing economies, but average growth remains below ...

Jan 24 (Reuters) - Hong Kong-based property developer New World Development (0017.HK), opens new tab on Friday confirmed it is conducting ongoing negotiations for the potential sale of its ...

“One of the most time-consuming and labor intensive parts of game development is coming up with hundreds of thousands of unique ideas,” Abe explained (via Automaton). He added that designs for ...

As 2025 begins to unfold, leadership and manager development has taken the top spot on HR leaders' list of priorities. According to a Gartner report, 70% of surveyed HR leaders feel their ...